Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹30,560.8
₹64,940 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,602.5
₹32,508 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹546.5
₹8,602 Cr
Pharmaceuticals & Drugs
₹796.5
₹7,219 Cr
Pharmaceuticals & Drugs
₹455.0
₹4,153 Cr
Pharmaceuticals & Drugs
₹290.1
₹3,246 Cr
Pharmaceuticals & Drugs
₹107.2
₹2,752 Cr
Pharmaceuticals & Drugs
₹110.2
₹536 Cr
Pharmaceuticals & Drugs
₹825.0
₹471 Cr
Pharmaceuticals & Drugs
₹54.2
₹154 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,602.5
₹4,648 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹546.5
₹4,145 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹455.0
₹2,387 Cr
Pharmaceuticals & Drugs
₹796.5
₹2,115 Cr
Pharmaceuticals & Drugs
₹290.1
₹637 Cr
Pharmaceuticals & Drugs
₹107.2
₹222 Cr
Pharmaceuticals & Drugs
₹30,560.8
₹6,409 Cr
Pharmaceuticals & Drugs
₹110.2
₹51 Cr
Pharmaceuticals & Drugs
₹825.0
₹346 Cr
Pharmaceuticals & Drugs
₹54.2
₹576 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,602.5
₹920 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹546.5
₹389 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹796.5
₹272 Cr
Pharmaceuticals & Drugs
₹455.0
₹168 Cr
Pharmaceuticals & Drugs
₹107.2
₹145 Cr
Pharmaceuticals & Drugs
₹290.1
₹134 Cr
Pharmaceuticals & Drugs
₹30,560.8
₹1,414 Cr
Pharmaceuticals & Drugs
₹110.2
₹2 Cr
Pharmaceuticals & Drugs
₹825.0
₹17 Cr
Pharmaceuticals & Drugs
₹54.2
₹6 Cr

You may also like the below Video Courses